Cambridge, UK, 24th April 2026 - Amphista Therapeutics ('the Company” or 'Amphista”), a leader in the discovery and development of non-cereblon/non-VHL Targeted Glue™ degraders, today announces the ...
With the rise of zero-click web searches, colleges are devising strategies for “answer-engine optimization,” or AEO.
For its 30th PCC anniversary, Insilico Medicine nominated ISM0387, the first UAE-based preclinical candidate, jointly ...
For the last decade, nephrology practices have navigated kidney care focused Center for Medicare and Medicaid Innovation (“Innovation ...
Tempus AI (TEM) stock fell 7.33% after announcing a precision medicine partnership with USC Keck Medicine covering 1.5M+ ...
A panel featured during the NAACOS Spring 2026 Conference featured 3 experts discussing different methods of encouraging more ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results